Pacific raises $200M in IPO

Pacific Biosciences Inc. (NASDAQ:PACB) raised $200 million through the sale of 12.5 million shares at $16 in an IPO underwritten by JPMorgan; Morgan Stanley; Deutsche Bank; and Piper Jaffray. The price came in at the midpoint of the proposed range of $15-$17 and values the company at $801.8 million. The company filed in August to raise up to $200 million. Pacific Biosciences was up $0.44 to $16.44 in its first day of trading on Wednesday. ...